Longitudinal adverse event assessment in oncology clinical trials: the Toxicity over Time (ToxT) analysis of Alliance trials NCCTG N9741 and 979254
about
Using Delayed Toxicities to Re-evaluate Tolerability in Phase 2 Trials: A Case Example using Bortezomib.Clinical Trials in the Genomic Era.Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients.Estimating global treatment toxicity burden from adverse-event data.Benefit-Risk Analysis for Decision-Making: An Approach.Randomized phase 2 study of tivantinib plus erlotinib versus single-agent chemotherapy in previously treated KRAS mutant advanced non-small cell lung cancer.The predictive value of cumulative toxicity for quality of life in patients with metastatic colorectal cancer during first-line palliative chemotherapy
P2860
Q38686511-4100A295-FCDD-4124-A769-232BFDE9BCDAQ38905607-D9C16A80-6127-45E7-AFEF-EB5E85C17014Q47135784-742C67D9-702B-4802-AF61-8F4DB7EB2B99Q47641160-02537E62-DFDA-4A16-B8F6-5B9728E570B2Q48770147-A0D7DCE2-B048-4AAF-9A41-12375653A2F1Q52678686-FE7F329F-1635-4191-B02B-4BC5725CA777Q57166865-4C34D8DE-886D-4F5B-90C2-8AB486EF0FBD
P2860
Longitudinal adverse event assessment in oncology clinical trials: the Toxicity over Time (ToxT) analysis of Alliance trials NCCTG N9741 and 979254
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Longitudinal adverse event ass ...... trials NCCTG N9741 and 979254
@en
Longitudinal adverse event assessment in oncology clinical trials: the Toxicity over Time
@nl
type
label
Longitudinal adverse event ass ...... trials NCCTG N9741 and 979254
@en
Longitudinal adverse event assessment in oncology clinical trials: the Toxicity over Time
@nl
prefLabel
Longitudinal adverse event ass ...... trials NCCTG N9741 and 979254
@en
Longitudinal adverse event assessment in oncology clinical trials: the Toxicity over Time
@nl
P2093
P2860
P1433
P1476
Longitudinal adverse event ass ...... trials NCCTG N9741 and 979254
@en
P2093
Axel Grothey
Charles L Loprinzi
Gita Thanarajasingam
Jeff A Sloan
Pamela J Atherton
Paul J Novotny
P2860
P304
P356
10.1016/S1470-2045(16)00038-3
P577
2016-04-12T00:00:00Z